A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2006
10/25/2006	EP1265606B1 Cell adhesion inhibitors
10/25/2006	CN1852923A Human antibody molecules for IL-13
10/25/2006	CN1852911A Epimeridinoside A and epimeredi indica root extract preparation containing same and preparing method therefor
10/25/2006	CN1852729A Antibacterial drug for propionibacterium acnes
10/25/2006	CN1852720A Pharmaceutical composition and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an estrogen agonist/antagonist
10/25/2006	CN1852719A Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bisphosphonate
10/25/2006	CN1852717A 2-alkylidene-19-nor-vitamin d derivatives for the treatment of osteopenia or male osteoporosis
10/25/2006	CN1852716A Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone
10/25/2006	CN1852709A Macrophage activation inhibitor
10/25/2006	CN1850264A Safflower preparation for treating wound and new preparing method
10/25/2006	CN1850257A Bone-setting powder
10/25/2006	CN1850238A Medicine composition for treating backbone and joint disease
10/25/2006	CN1850230A Chinese medicine composition for treating osteoporosis and preparing method
10/25/2006	CN1850227A Medicine for treating bone fracture
10/25/2006	CN1850223A Guandong-heiyao-Chinese medicine for treating bone nonunion
10/25/2006	CN1850221A Medicine composition for treating rheumatoid arthritis and rheumatism
10/25/2006	CN1850210A External-dressing Chinese medicine for bone-setting treatment
10/25/2006	CN1850192A Medicine composition for treating cerebral embolism sequela and rheumatoid arthritis and preparing method
10/25/2006	CN1850184A Dangejingshu tablet for treating cervical spondylosis and preparing method
10/25/2006	CN1850182A Injecta for treating hyperosteogeny and preparing method
10/25/2006	CN1850168A Water-lily-powder composition with function of compensating estrogen
10/25/2006	CN1850154A Liquid capsule of Radix seu Herba Phlomis Rotatae and preparing method
10/25/2006	CN1281606C Nitrogen-containing heterocyclic compound
10/25/2006	CN1281604C Substituted pyrazole compounds
10/25/2006	CN1281603C Aminopyrrole compounds as antiinflammatory agents
10/25/2006	CN1281601C Bipyridyl derivatives as a highly selective cyclooxygenase-2 inhibitor
10/25/2006	CN1281598C Compounds and methods for modulation of estrogen receptors
10/25/2006	CN1281590C Hexavalent amino amidate derivative with function of inhibiting blood vessel growth activity
10/25/2006	CN1281254C Injection for curing rheumatism and rheumatoid and preparation process thereof
10/25/2006	CN1281253C Chinese traditional medicine for treating disc protrusion and hyperosteogeny
10/25/2006	CN1281250C Prepared Chinese external medicine for reducing swelling and ease pain
10/25/2006	CN1281246C Traditional Chinese medicine extract with anti-inflammatory action and promoting blood circulation function, and its preparation method
10/25/2006	CN1281217C Use of activated carbon in oral medicinal preparation for hyperthyroidism
10/24/2006	US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/24/2006	US7125990 For treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
10/24/2006	US7125906 Indole derivatives having anti-angiogenetic activity
10/24/2006	US7125905 Pyrrole substituted 2-indolinone protein kinase inhibitors
10/24/2006	US7125900 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
10/24/2006	US7125899 Microtubule-stabilizing agents useful in the treatment of a variety of cancers
10/24/2006	US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents
10/24/2006	US7125895 Arylalkylamine compounds as chemokine receptor antagonists for therapy and prevention of diseases such as arthritis or rheumatic diseases
10/24/2006	US7125888 Tyrosine kinase inhibitors
10/24/2006	US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity
10/24/2006	US7125883 alpha v beta 3 integrin receptor modulators; treating variety of diseases including cardiovascular disorders, retinopathy, strokes, cancer, osteoporosis, tumor metastasis, high blood pressure, psoriasis, antiviral, antimycotic, antiparasitic or antibacterial therapy; 1,2-dihydropyrimidin-2-one moiety
10/24/2006	US7125881 Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives
10/24/2006	US7125878 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders
10/24/2006	US7125875 Cyclic protein tyrosine kinase inhibitors
10/24/2006	US7125873 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/24/2006	US7125866 Therapeutic applications of pro-apoptotic benzodiazepines
10/24/2006	US7125839 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
10/24/2006	US7125715 Nucleic acid encoding a polypeptide promoting type II collagen formation and aggrecan production
10/24/2006	US7125699 for treating solid tumours, macular degeneration, corneal rejection, psoriasis, rheumatoid arthritis and chronic ulceration, and diseases involving vascular insufficiency, including stroke and following heart attack
10/24/2006	US7125688 A feline hepatocyte growth factor gene and a 15 base pairs-deleted feline hepatocyte growth factor gene. These genes encode the following protein (a) or (b): a protein having an amino acid sequence shown in SEQ ID NO: 2 or 4; and a protein
10/24/2006	US7125686 Proteins and methods for producing the proteins
10/24/2006	US7125670 Comprises activated CD4 T-cells (ACT-4-L) ligand polypeptide for detection of immunomodulators; autoimmune diseases; drug screening; immunosuppressants; viricides
10/24/2006	CA2252717C Colchicine-skeleton compounds, their use as medicaments and compositions containing them
10/24/2006	CA2249402C Benzopyran derivatives having leukotriene-antagonistic action
10/24/2006	CA2205315C Fluorinated vitamin d3 analogs
10/19/2006	WO2006109867A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF
10/19/2006	WO2006109846A1 Triazole derivative and the use thereof
10/19/2006	WO2006108424A2 Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
10/19/2006	WO2006108229A1 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
10/19/2006	WO2006065975B1 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor
10/19/2006	US20060235058 Substituted 5-membered ring compounds and their use
10/19/2006	US20060235057 Phenyl compounds
10/19/2006	US20060235054 e.g. 3-substituted 5-(4-fluorophenyl)-4-(4-pyridyl)imidazole-2-thione; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
10/19/2006	US20060235033 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor
10/19/2006	US20060235026 Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/19/2006	US20060235023 Inhibitors of macrophage migration inhibitory factor and methods for indentifying the same
10/19/2006	US20060235002 Novel physiologically active substance
10/19/2006	US20060234991 Combinations for the treatment of immunoinflammatory disorders
10/19/2006	US20060234937 Modulation of angiogenesis
10/19/2006	US20060234921 Treatment of osteoarthritis
10/19/2006	US20060233833 Novel uses of parapoxvirus preparations
10/19/2006	US20060233811 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
10/19/2006	US20060233800 Biological products
10/19/2006	US20060233799 Use of il-18 inhibitors for treatment and/or prevention of peripheral vascular diseases
10/19/2006	US20060233724 Medicinal composition for peridontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient
10/19/2006	CA2604758A1 Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
10/19/2006	CA2604493A1 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
10/19/2006	CA2604443A1 Use of anti-ngf antibody for improving stiffness in osteoarthritis
10/19/2006	CA2603457A1 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
10/18/2006	EP1711531A2 Neutralizing antibodies and methods of use thereof
10/18/2006	EP1711507A1 Crystalline form of risedronate monosodium
10/18/2006	EP1711475A1 2-(phenylamino)-pyrimidin-5-amides as cannabinoid 2 receptors modulators for the treatment of immune or inflammatory disorders.
10/18/2006	EP1711202A1 Treatment of bone metastases by means of pth receptor agonists
10/18/2006	EP1711177A1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS
10/18/2006	EP1711175A1 Diurea derivatives
10/18/2006	EP1572683B1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
10/18/2006	EP1534305B1 Treating cartilage / bone conditions with water-soluble strontium salts
10/18/2006	EP1332206B1 Recombinant alpha-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
10/18/2006	EP1326654B1 Methods and compositions for tissue regeneration
10/18/2006	EP1325749B1 Use of a bone metabolism improving agent
10/18/2006	EP1239850B1 Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chloride as anti-inflammatory agents
10/18/2006	EP1208196B1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/18/2006	EP1128815B1 Process for preparing oral calcium compositions
10/18/2006	EP1119611B1 Composition for use in chemonucleolysis
10/18/2006	EP1107957B1 Pyrimidine compounds
10/18/2006	CN1849400A Polynucleotides and polypeptides of the erythropoietin gene
10/18/2006	CN1849135A Methods for treating interleukin-6-related diseases

1 ... 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 ... 820